NYSE - Nasdaq Real Time Price • USD
Corteva, Inc. (CTVA)
As of 11:16 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 23 | 22 |
| Avg. Estimate | 0.84 | 1.82 | 2.83 | 3.43 |
| Low Estimate | 0.69 | 1.5 | 2.7 | 2.99 |
| High Estimate | 1.09 | 2 | 3.03 | 3.75 |
| Year Ago EPS | 1.16 | 1.6 | 2.69 | 2.83 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 22 | 21 |
| Avg. Estimate | 4.65B | 6.24B | 17.57B | 18.36B |
| Low Estimate | 4.28B | 6.08B | 17.32B | 17.64B |
| High Estimate | 4.93B | 6.5B | 17.93B | 19.04B |
| Year Ago Sales | 4.88B | -- | 17.23B | 17.57B |
| Sales Growth (year/est) | -4.90% | -- | 2.00% | 4.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.93 | 1.58 | -0.23 | 0.06 |
| EPS Actual | 1.16 | 1.6 | -0.23 | 0.15 |
| Difference | 0.23 | 0.02 | 0 | 0.09 |
| Surprise % | 24.70% | 1.30% | 0.00% | 150.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.84 | 1.82 | 2.83 | 3.43 |
| 7 Days Ago | 0.87 | 1.8 | 2.84 | 3.43 |
| 30 Days Ago | 0.95 | 1.76 | 2.84 | 3.44 |
| 60 Days Ago | 0.98 | 1.73 | 2.84 | 3.43 |
| 90 Days Ago | 1.05 | 1.79 | 3.01 | 3.44 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 3 | -- | 2 |
| Up Last 30 Days | 1 | 9 | -- | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 1 | 4 | 1 |
Growth Estimates
| CURRENCY IN USD | CTVA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -27.60% | -- | -- | 0.80% |
| Next Qtr. | 13.70% | -- | -- | 9.60% |
| Current Year | 5.20% | -- | -- | 4.50% |
| Next Year | 21.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 11.95% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 4.08% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 4/16/2024 |
| Downgrade | JP Morgan: Overweight to Neutral | 4/12/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/10/2024 |
| Maintains | Keybanc: Overweight to Overweight | 4/9/2024 |
| Initiated | Wolfe Research: Outperform | 3/1/2024 |
| Upgrade | Loop Capital: Hold to Buy | 2/12/2024 |
Related Tickers
FMC FMC Corporation
57.43
+0.86%
MOS The Mosaic Company
30.90
+1.40%
NTR Nutrien Ltd.
52.80
+0.28%
CF CF Industries Holdings, Inc.
80.21
+0.77%
SMG The Scotts Miracle-Gro Company
67.59
-0.54%
IPI Intrepid Potash, Inc.
19.66
+0.72%
BIOX Bioceres Crop Solutions Corp.
12.19
-0.37%
UAN CVR Partners, LP
77.37
+2.00%
AVD American Vanguard Corporation
11.17
+0.72%
ICL ICL Group Ltd
4.7150
+1.18%